92 related articles for article (PubMed ID: 29729907)
1. Technical note: p40 antibody as a replacement for p63 antibody in bovine mammary immunohistochemistry.
Parsons CLM; Tucker HLM; Akers RM; Daniels KM
J Dairy Sci; 2018 Aug; 101(8):7614-7617. PubMed ID: 29729907
[TBL] [Abstract][Full Text] [Related]
2. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.
Uchida K; Ross H; Lotan T; Pignon JC; Signoretti S; Epstein JI; Illei PB
Hum Pathol; 2015 Mar; 46(3):384-9. PubMed ID: 25548110
[TBL] [Abstract][Full Text] [Related]
3. Comparison of p63 and p40 (ΔNp63) as Basal, Squamoid, and Myoepithelial Markers in Salivary Gland Tumors.
Owosho AA; Aguilar CE; Seethala RR
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):501-8. PubMed ID: 26230372
[TBL] [Abstract][Full Text] [Related]
4. Comparison of p40 (ΔNp63) and p63 expression in prostate tissues--which one is the superior diagnostic marker for basal cells?
Sailer V; Stephan C; Wernert N; Perner S; Jung K; Dietel M; Kristiansen G
Histopathology; 2013 Jul; 63(1):50-6. PubMed ID: 23668398
[TBL] [Abstract][Full Text] [Related]
5. Tumour 63 protein (p63) in breast pathology: biology, immunohistochemistry, diagnostic applications, and pitfalls.
Alkhayyat R; Abbas A; Quinn CM; Rakha EA
Histopathology; 2024 Apr; 84(5):723-741. PubMed ID: 38012539
[TBL] [Abstract][Full Text] [Related]
6. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
7. Characterization of specific p63 and p63-N-terminal isoform antibodies and their application for immunohistochemistry.
Nekulova M; Holcakova J; Nenutil R; Stratmann R; Bouchalova P; Müller P; Mouková L; Coates PJ; Vojtesek B
Virchows Arch; 2013 Sep; 463(3):415-25. PubMed ID: 23887585
[TBL] [Abstract][Full Text] [Related]
8. p40 (ΔNp63) is more specific than p63 and cytokeratin 5 in identifying squamous cell carcinoma of bronchopulmonary origin: a review and comparative analysis.
Vogt AP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2014 May; 42(5):453-8. PubMed ID: 24166777
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical analysis of a newly developed, mouse monoclonal p40 (BC28) antibody in lung, bladder, skin, breast, prostate, and head and neck cancers.
Tacha D; Bremer R; Haas T; Qi W
Arch Pathol Lab Med; 2014 Oct; 138(10):1358-64. PubMed ID: 24528495
[TBL] [Abstract][Full Text] [Related]
10. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.
Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW
J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756
[TBL] [Abstract][Full Text] [Related]
11. Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.
Sailer V; Lüders C; Kuhn W; Pelzer V; Kristiansen G
Virchows Arch; 2015 Jul; 467(1):67-70. PubMed ID: 25850754
[TBL] [Abstract][Full Text] [Related]
12. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology.
Khazai L; Agosto-Arroyo E; Rosa M
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Detection of p40 Expression in Lung Cancer Clinical Samples.
Nambirajan A; Jain D
Methods Mol Biol; 2021; 2279():13-21. PubMed ID: 33683682
[TBL] [Abstract][Full Text] [Related]
14. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
Alomari AK; Glusac EJ; McNiff JM
J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
[TBL] [Abstract][Full Text] [Related]
15. p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry.
Kim SK; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(3):1032-41. PubMed ID: 24696720
[TBL] [Abstract][Full Text] [Related]
16. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
17. Benign and malignant odontogenic neoplasms of the jaws show a concordant nondiscriminatory p63/p40 positive immunophenotype.
Argyris PP; Malz C; Taleb R; Koutlas IG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Dec; 126(6):506-512. PubMed ID: 30309829
[TBL] [Abstract][Full Text] [Related]
18. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
19. Pan-p63 but not ΔNp63 (p40) expression in undifferentiated carcinoma of the pancreas.
Liszka Ł
Pol J Pathol; 2020; 71(2):155-172. PubMed ID: 32729306
[TBL] [Abstract][Full Text] [Related]
20. TAp63 and ΔNp63 (p40) in prostate adenocarcinomas: ΔNp63 associates with a basal-like cancer stem cell population but not with metastasis.
Galoczova M; Nenutil R; Pokorna Z; Vojtesek B; Coates PJ
Virchows Arch; 2021 Apr; 478(4):627-636. PubMed ID: 33037932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
